Retro Biosciences Begins First-in-Human Trial of Anti-Aging Therapy RTR242
Longevity-focused biotech company Retro Biosciences has launched a Phase 1 first-in-human clinical trial of its experimental therapy, RTR242, marking a significant milestone in the rapidly evolving field of anti-aging research. The trial represents the earliest step in testing the treatment in people and is primarily designed to assess its safety and tolerability. RTR242 is engineered…
